Insiders · TMCI

TMCI insider transactions

Treace Medical Concepts Inc. (TMCI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for TMCI

• 1d
  Chief Executive Officer Treace John T. bought $177,915 worth of shares (50,000 units at $3.56), increasing direct ownership by 0.69% to 7,323,833 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 5d
  Chief Executive Officer Treace John T. bought $340,589 worth of shares (115,520 units at $2.95), increasing direct ownership by 2% to 7,273,833 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 14d
  Director Jain Deepti was granted 30,000 shares, increasing direct ownership by 43% to 100,243 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 14d
  Director Bakewell John K was granted 30,000 shares, increasing direct ownership by 17% to 204,056 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 14d
  Director Kiernan Jane E was granted 30,000 shares, increasing direct ownership by 47% to 93,949 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 14d
  Director Berry Lance A was granted 30,000 shares, increasing direct ownership by 67% to 74,593 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 14d
  Director Hanna Betsy was granted 30,000 shares, increasing direct ownership by 66% to 75,243 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 14d
  Director Hamilton Lawrence W was granted 30,000 shares, increasing direct ownership by 68% to 74,056 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 19d
  Chief Executive Officer Treace John T. bought $375,505 worth of shares (153,763 units at $2.44), increasing direct ownership by 2% to 7,158,313 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 43d
  SEC Form 4 filed by Hair Mark

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 60d
  SEC Form 4 filed by Hair Mark

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 83d
  Chief Executive Officer Treace John T. covered exercise/tax liability with 7,083 shares, decreasing direct ownership by 0.10% to 7,004,550 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 83d
  Chief Financial Officer Hair Mark covered exercise/tax liability with 4,659 shares, decreasing direct ownership by 0.54% to 863,549 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 83d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 1,850 shares, decreasing direct ownership by 0.23% to 794,936 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 83d
  Chief Innovation Officer Scanlan Sean F. covered exercise/tax liability with 1,797 shares, decreasing direct ownership by 0.25% to 704,677 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 111d
  Chief Innovation Officer Scanlan Sean F. exercised 16,875 shares at a strike of $1.05, increasing direct ownership by 2% to 706,474 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 130d
  Chief Innovation Officer Scanlan Sean F. exercised 53,500 shares at a strike of $0.72 and was granted 262,500 shares, increasing direct ownership by 85% to 689,599 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 130d
  Chief Executive Officer Treace John T. covered exercise/tax liability with 14,254 shares and was granted 250,000 shares, increasing direct ownership by 3% to 7,011,633 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 130d
  Chief Commercial Officer Guglielmino Gaetano was granted 150,000 shares, increasing direct ownership by 44% to 490,901 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 130d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 9,451 shares and was granted 262,500 shares, increasing direct ownership by 47% to 796,786 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 130d
  Chief Financial Officer Hair Mark covered exercise/tax liability with 17,037 shares and was granted 375,000 shares, increasing direct ownership by 70% to 868,208 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 140d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 4,544 shares, decreasing direct ownership by 0.83% to 543,737 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 140d
  Chief Executive Officer Treace John T. covered exercise/tax liability with 13,219 shares, decreasing direct ownership by 0.19% to 6,775,887 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 140d
  Chief Financial Officer Hair Mark covered exercise/tax liability with 8,719 shares, decreasing direct ownership by 2% to 510,245 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 181d
  Chief Commercial Officer Guglielmino Guy covered exercise/tax liability with 22,099 shares, decreasing direct ownership by 6% to 340,901 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 217d
  Chief Innovation Officer Scanlan Sean F. covered exercise/tax liability with 208 shares, decreasing direct ownership by 0.06% to 373,599 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 217d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 984 shares, decreasing direct ownership by 0.18% to 548,281 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 243d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 16,884 shares, decreasing direct ownership by 3% to 549,265 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 294d
  Chief Financial Officer Hair Mark covered exercise/tax liability with 22,212 shares, decreasing direct ownership by 4% to 518,964 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 294d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 10,515 shares, decreasing direct ownership by 2% to 566,149 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 294d
  SVP, Sales Berutti Aaron covered exercise/tax liability with 4,907 shares, decreasing direct ownership by 2% to 205,092 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 294d
  Chief Innovation Officer Scanlan Sean F. covered exercise/tax liability with 9,814 shares, decreasing direct ownership by 3% to 373,807 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 315d
  Chief Innovation Officer Scanlan Sean F. exercised 33,437 shares at a strike of $0.72, increasing direct ownership by 10% to 383,621 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 377d
  Director Jain Deepti was granted 23,917 shares, increasing direct ownership by 52% to 70,243 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 377d
  Director Mott Richard W was granted 23,917 shares, increasing direct ownership by 2% to 1,096,861 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 377d
  Director Hanna Betsy was granted 23,917 shares, increasing direct ownership by 112% to 45,243 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 377d
  Director Hamilton Lawrence W was granted 23,917 shares, increasing direct ownership by 119% to 44,056 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 377d
  Director Berry Lance A was granted 23,917 shares, increasing direct ownership by 116% to 44,593 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 377d
  Director Kiernan Jane E was granted 23,917 shares, increasing direct ownership by 60% to 63,949 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 377d
  Director Bakewell John K was granted 23,917 shares, increasing direct ownership by 16% to 174,056 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 386d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael was granted 7,775 shares and covered exercise/tax liability with 1,894 shares, increasing direct ownership by 1% to 576,664 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 440d
  Chief Innovation Officer Scanlan Sean F. exercised 50,000 shares at a strike of $1.05 and sold $398,460 worth of shares (50,000 units at $7.97) (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 448d
  SVP, Sales Berutti Aaron covered exercise/tax liability with 2,543 shares, decreasing direct ownership by 1% to 209,999 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 448d
  Chief Executive Officer Treace John T. covered exercise/tax liability with 7,084 shares, decreasing direct ownership by 0.10% to 6,789,106 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 448d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 1,851 shares, decreasing direct ownership by 0.32% to 570,783 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 448d
  Chief Innovation Officer Scanlan Sean F. covered exercise/tax liability with 1,797 shares, decreasing direct ownership by 0.49% to 364,081 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 448d
  Chief Financial Officer Hair Mark covered exercise/tax liability with 4,645 shares, decreasing direct ownership by 0.85% to 541,176 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 455d
  Chief Executive Officer Treace John T. bought $524,064 worth of shares (60,000 units at $8.73), increasing direct ownership by 0.89% to 6,796,190 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 494d
  Chief Executive Officer Treace John T. was granted 225,000 shares, increasing direct ownership by 3% to 6,736,190 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 494d
  Chief Financial Officer Hair Mark was granted 187,500 shares, increasing direct ownership by 52% to 546,821 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 494d
  Chief Innovation Officer Scanlan Sean F. was granted 140,625 shares, increasing direct ownership by 62% to 365,878 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 494d
  SVP, Sales Berutti Aaron was granted 75,000 shares, increasing direct ownership by 55% to 212,542 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 494d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael was granted 127,500 shares, increasing direct ownership by 29% to 572,634 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 504d
  Chief Financial Officer Hair Mark covered exercise/tax liability with 8,594 shares, decreasing direct ownership by 2% to 359,321 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 504d
  SVP, Sales Berutti Aaron covered exercise/tax liability with 4,821 shares, decreasing direct ownership by 3% to 160,970 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 504d
  Chief Executive Officer Treace John T. covered exercise/tax liability with 11,905 shares, decreasing direct ownership by 0.18% to 6,511,190 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 504d
  Chief Innovation Officer Scanlan Sean F. covered exercise/tax liability with 4,821 shares, decreasing direct ownership by 2% to 225,253 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 504d
  Chief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 4,544 shares, decreasing direct ownership by 1% to 445,134 units (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 544d
  Chief Commercial Officer Guglielmino Guy was granted 363,000 shares (SEC Form 4)

  4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
• 544d
  New insider Guglielmino Guy claimed no ownership of stock in the company (SEC Form 3)

  3 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)